European Concerted Action on Anticoagulation

Summary

A procedure for using citrated fresh plasmas for International Sensitivity Index (ISI) calibration of two types of whole blood point-of-care test (POCT) prothrombin time (PT) monitor systems has been assessed in a multicentre study.

The CoaguChek Mini and TAS PT-NC systems gave higher ISI with whole blood samples than with fresh plasma calibrations. However, there was good agreement between whole blood and fresh plasma monitor system International Normalised Ratio (INR) and the reference INR of target samples.

Reliable INR can therefore be obtained with both whole blood and plasma samples on these two POCT systems based on their respective ISI. With the CoaguChek Mini system, the plasma calibration ISI can also be used to derive reliable INR with whole blood PT results. This was not possible with the TAS PT-NC system.

Keywords

Prothrombin time - International Normalised Ratio - plasma calibrations - Multicentre ISI - POCT monitors

^* European Concerted Action on Anticoagulation Steering Group Members

• References

• 1 Ansell J, Hirsh J, Dalen J, Bussey H, Anderson D, Poller L, Jacobson A, Deykin D, Matchar D. Management of oral anticoagulant therapy. Chest 2001; 119: 22S-38S.
• 2 WHO Expert Committee on Biological Standardisation. 33rd Report. WHO Technical Report Series 1983; 687: 81-105.
• 3 WHO Guidelines for thromboplastins and plasma used to control oral anticoagulation therapy. Annex 3. WHO Technical Report Series 1999; 889: 64-93.
• 4 Tripodi A, Arbini AA, Chantarangkul V, Bettega D, Mannucci PM. Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the International Normalized Ratio?. Thromb Haemost 1993; 70: 921-4.
• 5 Poller L, Keown M, Chauhan N, van den Besselaar AMHP, Meeuwisse-Braun J, Tripodi A, Clerici M, Jespersen J. European Concerted Action on Anticoagulation (ECAA). The use of plasma samples to derive International Sensitivity Index of whole blood Prothrombin Time Monitors. Clin Chem 2002; 48: 255-60.
• 6 Tripodi A, Chantarangkul V, Negri B, Clerici M, Mannucci PM. International Collaborative Study for the Calibration of a proposed Reference Preparation for Thromboplastin, Human Recombinant, Plain. Thromb Haemost 1998; 79: 439-43.
• 7 van den Besselaar AMHP. Multicenter study of replacement of the International Reference Preparation for Thromboplastin, Rabbit, Plain. Thromb Haemost 1993; 70: 794-9.
• 8 Tripodi A, Chantarangkul V, Clerici M, Negri B, Mannucci PM. Determination of the ISI of a new near-patient testing device to monitor oral anticoagulant therapy. Thromb Haemost 1997; 78: 855-8.
• 9 Tomenson JA. A statistician’s independent evaluation. van den Besselaar AMHP, Lewis SM, Gralnick HR. Thromboplastin calibration and oral anticoagulant control. Boston, Mass: Martinus Nijhoff; 1984: 7-108.
• 10 van den Besselaar AMHP. A comparison of INRs determined with a whole blood prothrombin device and two International Reference Preparations for Thromboplastin. Thromb Haemost 2000; 84: 410-2.
• 11 Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet 1995; 346: 1085-7.
• 12 Gosselin R, Owings JT, White RH, Hutchinson Branch J, Mahackian K, Johnston M, Larkin EC. A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods. Thromb Haemost 2000; 83: 698-703.
• 13 Poller L, Keown M, Chauhan N, van den Besselaar AMHP, Meeuwisse-Braun J, Clerici M, Tripodi A, Jespersen J. European Concerted Action on Anticoagulation (ECAA). Prothrombin Time and International Normalised Ratio variability of CoaguChek and TAS Point-of-Care Testing Prothrombin Time Monitors. To be published.